Health and Economic Benefits of Early Vaccination and Nonpharmaceutical Interventions for a Human Influenza A (H7N9) Pandemic-Reference-Cited by-同舟云学术

Health and Economic Benefits of Early Vaccination and Nonpharmaceutical Interventions for a Human Influenza A (H7N9) Pandemic

Published:2014-05-20 Issue:10 Volume:160 Page:684
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Khazeni Nayer¹,Hutton David W.¹,Collins Cassandra I.F.¹,Garber Alan M.¹,Owens Douglas K.¹

Affiliation:

1. From Stanford University Medical Center and Center for Health Policy/Center for Primary Care and Outcomes Research, Stanford, California; University of Michigan, Ann Arbor, Michigan; Harvard University, Cambridge, Massachusetts; and Veterans Affairs Palo Alto Health Care System, Palo Alto, California.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infectious disease modelling for SARS-CoV-2 in Africa to guide policy: A systematic review;Epidemics;2022-09

2. Non-Pharmaceutical Interventions Implemented to Control the COVID-19 Were Associated With Reduction of Influenza Incidence;Frontiers in Public Health;2022-02-18

3. Effectiveness of non-pharmaceutical interventions related to social distancing on respiratory viral infectious disease outcomes: A rapid evidence-based review and meta-analysis;SAGE Open Medicine;2021-01

4. Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature;The European Journal of Health Economics;2020-08-13

5. Antiviral Activity of Chicken Cathelicidin B1 Against Influenza A Virus;Frontiers in Microbiology;2020-03-19